trial · primary record
Placebo
Healthy Volunteers
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 57 |
| Primary completion | 2024-07-31 |
| Primary endpoint | To assess the safety and tolerability of a single ascending IV dose of AX-202 in healthy subjects and multiple ascending IV doses of AX-202 in patients with mild to moderate chronic plaque psoriasis by monitoring of adverse events. |
| Registry ID | NCT05965089 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:01.971Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05965089
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound